These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1615477)

  • 1. The effect of DDAVP and placebo on platelet function and prolonged bleeding time induced by oral acetyl salicylic acid intake in healthy volunteers.
    Lethagen S; Rugarn P
    Thromb Haemost; 1992 Jan; 67(1):185-6. PubMed ID: 1615477
    [No Abstract]   [Full Text] [Related]  

  • 2. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin].
    Beck KH; Bleckmann U; Mohr P; Kretschmer V; Huss B
    Beitr Infusionsther Transfusionsmed; 1994; 32():437-9. PubMed ID: 9480140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction.
    Sheridan DP; Card RT; Pinilla JC; Harding SM; Thomson DJ; Gauthier L; Drotar D
    Can J Surg; 1994 Feb; 37(1):33-6. PubMed ID: 8306217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients.
    Malyszko J; Pietraszek M; Buczko W; Mysliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):319-24. PubMed ID: 1697836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemostatic control in platelet dysfunction and abnormality by DDAVP].
    Mito M; Higuchi W; Fuse I; Hattori A; Shibata A
    Nihon Rinsho; 1992 Feb; 50(2):355-9. PubMed ID: 1613990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo effects of desmopressin on platelet function.
    Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
    Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.
    Kobrinsky NL; Israels ED; Gerrard JM; Cheang MS; Watson CM; Bishop AJ; Schroeder ML
    Lancet; 1984 May; 1(8387):1145-8. PubMed ID: 6144876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmopressin stimulates the expression of P-selectin on human platelets in vitro.
    Wun T; Paglieroni TG; Lachant NA
    J Lab Clin Med; 1995 Oct; 126(4):401-9. PubMed ID: 7561450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of DDAVP administrated subcutaneously in dogs with aspirin-induced platelet dysfunction and hemostatic impairment due to chronic liver diseases.
    Sakai M; Watari T; Miura T; Maruyama H; Koie H; Yamaya Y; Takeuchi A; Hasegawa A
    J Vet Med Sci; 2003 Jan; 65(1):83-6. PubMed ID: 12576709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time.
    Cattaneo M; Pareti FI; Zighetti M; Lecchi A; Lombardi R; Mannucci PM
    J Lab Clin Med; 1995 Apr; 125(4):540-7. PubMed ID: 7706911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of aspirin and linoleic acid on platelet aggregation, platelet fatty acid composition and haemostasis in man.
    Challen AD; Branch WJ; Cummings JH
    Hum Nutr Clin Nutr; 1983 May; 37(3):197-208. PubMed ID: 6874413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
    Escolar G; Cases A; Monteagudo J; Garrido M; Lopez J; Ordinas A; Revert L; Castillo R
    J Lab Clin Med; 1989 Jul; 114(1):36-42. PubMed ID: 2738447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin, DDAVP and the bleeding time.
    Schulman S; Johnsson H
    Thromb Haemost; 1991 Mar; 65(3):242-4. PubMed ID: 2048049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of desmopressin acetate (DDAVP) and dextran on hemostatic and thromboprophylactic mechanisms.
    Lethagen S; Rugarn P; Aberg M; Nilsson IM
    Acta Chir Scand; 1990 Sep; 156(9):597-602. PubMed ID: 1702252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
    Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
    Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic and hemodynamic effects of vasopressin analogue DDAVP in patients with cirrhosis.
    López P; Otaso JC; Alvarez D; Rojter S; Podestá A; Albornoz L; Terg R; Romero G; Mastai R
    Acta Gastroenterol Latinoam; 1997; 27(2):59-62. PubMed ID: 9339235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with prolonged bleeding time of undefined etiology, and their response to desmopressin.
    Kim HC; Salva K; Fallot PL; Karp GI; Eisele J; Matts L; Heller I; Saidi P
    Thromb Haemost; 1988 Apr; 59(2):221-4. PubMed ID: 3388295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time in uremic patients].
    Alarcón F; Mezzano D; Vial S; Pereira J
    Rev Med Chil; 1985 Aug; 113(8):763-8. PubMed ID: 3938558
    [No Abstract]   [Full Text] [Related]  

  • 19. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
    Mannucci PM
    Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
    Pfueller SL; Howard MA; White JG; Menon C; Berry EW
    Thromb Haemost; 1987 Dec; 58(4):1060-3. PubMed ID: 3502198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.